
Keywords: AF, amniotic fluids; AP-1, activator protein-1; CSAIDs, cytokine suppressive anti-inflammatory drugs; DAMPs, damage-associated molecular patterns; ECM, extracellular matrix; fFN, fetal fibronectin; HPA, hypothalamic-pituitary-adrenal; IKK, IκB kinase; IL,